Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Active, not recruiting · NCT04866680 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Not applicable | 2026-09-01 | NCT04866680 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut de Cancérologie de Lorraine | 10 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CGFL | Dijon | France | 3 |
| CHRU Lille | Lille | France | 32 |
| CHRU Nancy | Vandœuvre-lès-Nancy | France | 5 |
| CHU Dijon | Dijon | France | 37 |
| CHU Jean Minjoz | Besançon | France | 13 |
| Ghr Mulhouse Sud Alsace | Mulhouse | France | 3 |
| Institut de Cancerologie de Lorraine | Vandœuvre-lès-Nancy | France | 12 |
| Institut Godinot | Reims | France | 12 |